Bio Pharma Dive
FEBRUARY 3, 2021
While the biotech prepares to launch aducanumab, its latest earnings report shows significant hits to top-selling drugs, plus another pipeline failure.
World of DTC Marketing
FEBRUARY 3, 2021
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. It’s reshaping the company to once again focus on patients instead of profits. At the end of last year, I worked with a leading cancer company on a test program that involved an email program. We started with research to uncover the needs and wants of current cancer patients (NSC lung) and caregivers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 3, 2021
Nine other drug developers are set to price initial public offerings this week, extending a record run of financing activity from last year. Sana's is one of the largest in history.
Pharma Times
FEBRUARY 3, 2021
The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
FEBRUARY 3, 2021
The cash-and-stock deal gives Jazz, best known for its sleep disorder drugs, access to Epidiolex, the first prescription cannabidiol medicine approved by the FDA.
NY Times
FEBRUARY 3, 2021
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 3, 2021
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.
Bio Pharma Dive
FEBRUARY 3, 2021
The U.K. drugmaker will help CureVac make 100 million doses of its coronavirus vaccine and join in developing a multivalent shot for 2022.
BioSpace
FEBRUARY 3, 2021
On the other hand, when dealing with a novel coronavirus, a certain amount of speed and urgency is necessary. Professor Chris Molloy, Chief Executive Officer of the U.K,’s Medicines Discovery Catapult, told BioSpace that real-time data should be considered, with a different lens applied.
Drug Patent Watch
FEBRUARY 3, 2021
This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve…. The post The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
FEBRUARY 3, 2021
COVID-19 vaccines have been a topic of conversation since the outbreak began, and last year’s US Food and Drug Administration (FDA) approval of the Pfizer/BioNTech and Moderna vaccines have given the world hope to defeat the COVID-19 pandemic. Many countries have begun to provide their citizens with the vaccine to accelerate curbing the spread of the novel coronavirus.
pharmaphorum
FEBRUARY 3, 2021
NICE has recommended regular NHS funding for Novartis’ long-acting eye drug Beovu (brolucizumab) in England and Wales – but a patient group warned that access could be limited until the pandemic recedes because of disruption to ophthalmology clinics. In final guidance NICE said trials have shown Novartis’ Beovu has similar efficacy in wet advanced macular degeneration (AMD) to rival Eylea (aflibercept) from Bayer/Regeneron and Novartis predecessor Lucentis (ranibizumab).
XTalks
FEBRUARY 3, 2021
Italian pasta giant Barilla has finalized the acquisition of Catelli , a Montreal, Canada-based pasta firm in a deal worth around $130 million. Along with Catelli, Barilla has also acquired Lancia and Splendor pasta brands as well as a manufacturing plant in Montreal, Quebec as per the deal signed in October 2020. The acquisition closed late last week on January 29.
Scienmag
FEBRUARY 3, 2021
Effects of unhealthy food followed young mice into adulthood Credit: UCR Eating too much fat and sugar as a child can alter your microbiome for life, even if you later learn to eat healthier, a new study in mice suggests. The study by UC Riverside researchers is one of the first to show a significant […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
FEBRUARY 3, 2021
Roche is closing out its fourth-quarter with some house cleaning. The Swiss pharma giant announced in its earnings report that it was terminating studies of several mid- and late-stage assets, including two late-stage breast cancer programs.
Scienmag
FEBRUARY 3, 2021
Awards announced by The Paul G. Allen Frontiers Group will fund research in health, disease, and technology development all centered on the emerging field of immunometabolism Credit: Katharine Ng, Tropini Lab, University of British Columbia Just like us, immune cells need fuel to do their jobs. Despite the tight links between human health — including […].
BioSpace
FEBRUARY 3, 2021
Anaphylaxis is a serious and potentially fatal allergy to bee venom, food, and medication, and only 50-60% of the affected population is adequately prepared for an attack. Even less are prepared in severe cases where a second dose is required.
Pharma Times
FEBRUARY 3, 2021
Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
FEBRUARY 3, 2021
Researchers develop low-cost artificial robotic skin with high-performance, vision-guided sensing, opening the doors to large-scale tactile sensing technology Credit: Courtesy: Prof. Van Anh Ho from JAIST Modern-day robots are often required to interact with humans intelligently and efficiently, which can be enabled by providing them the ability to perceive touch.
BioSpace
FEBRUARY 3, 2021
The University of Oxford in the U.K., with the National Immunisation Schedule Evaluation Consortium, is planning a trial to evaluate the use of first and second doses of different COVID-19 vaccines.
Scienmag
FEBRUARY 3, 2021
Credit: Beyene Zewdie Coffee rust is a parasitic fungus and a big problem for coffee growers around the world. A study in the birthplace of coffee – Ethiopia – shows that another fungus seems to have the capacity to supress the rust outbreaks in this landscape. “Coffee leaf rust is a fungal disease that is […].
BioSpace
FEBRUARY 3, 2021
Amgen is in the process of eliminating hundreds of U.S. jobs, the majority of which are centered on the company’s sales team, according to a recent sales call.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
FEBRUARY 3, 2021
Credit: UBC In the race to stop the spread of COVID-19, a three-layer cloth mask that fits well can effectively filter COVID particles, says a group of UBC researchers. After testing several different mask styles and 41 types of fabrics, they found that a mask consisting of two layers of low-thread-count quilting cotton plus a […].
BioSpace
FEBRUARY 3, 2021
Not every biotech job is heavily rooted in science. Some rely on additional skills, like those of communication, organization and more in order to play a crucial role in the industry.
Scienmag
FEBRUARY 3, 2021
This Aging-US study showed that deep learning programs such as Xception have the ability to differentiate the faces of patients with mild dementia from that of patients without dementia. Credit: Correspondence to: Masashi Kameyama email: kame-tky@umin.ac.jp Aging-US published “Screening of Alzheimer’s disease by facial complexion using artificial intelligence” which reported that despite the increasing incidence […].
BioSpace
FEBRUARY 3, 2021
From packaging errors and contaminants to serious adverse effects, there are many reasons why products in the life sciences industry get recalled. Here’s a look at some of the latest drug and medical device recalls.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
FEBRUARY 3, 2021
New study defies conventions and proposes a technology-driven method to identify useful catalyst combinations Credit: JAIST To date, research in the field of combinatorial catalysts has relied on serendipitous discoveries of catalyst combinations. Now, scientists from Japan have streamlined a protocol that combines random sampling, high-throughput experimentation, and data science to identify synergistic combinations of […].
Cloudbyz
FEBRUARY 3, 2021
Products. Enterprise IT. Project Portfolio Management (PPM). Resource Management. Agile Portfolio Management. IT Business Management (ITBM). Healthcare & Lifesciences. Clinical Trial Management (CTMS). R&D Portfolio Management. Clinical Trial Budget Management. Study Start-up. Patient Recruitment. Electronic Trial Master File (eTMF). Investigator Portal.
Scienmag
FEBRUARY 3, 2021
Credit: RUDN University Mathematicians from RUDN University suggested and tested a new method to assess the productivity of fifth-generation (5G) base stations. The new technology would help get rid of mobile access stations and even out traffic fluctuations. The results of the study were published in the IEEE Conference Publication. Stations of the new 5G […].
BioSpace
FEBRUARY 3, 2021
Pfizer struck a collaboration and licensing agreement with Belgium-based Imcyse for a rheumatoid arthritis program, which is based on that company’s Imotope technology.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
343 
Let's personalize your content